SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(Amendment No. 3)(1)
NMT Medical, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
629294 10 9
- --------------------------------------------------------------------------------
(CUSIP Number)
December 31, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|_| Rule 13d-1(c)
|X| Rule 13d-1(d)
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
- ---------------------- ------------------
CUSIP No. 629294 10 9 13G Page 2 of 6 Pages
- ---------------------- ------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Fletcher Spaght, Inc.
ID# 04-2950171
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
587,352 shares (includes 83,329 shares which Fletcher
Spaght, Inc. has the right to acquire within 60 days
after December 31, 1999)
------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY 0 shares
EACH ------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH 587,352 shares (includes 83,329 shares which Fletcher
Spaght, Inc. has the right to acquire within 60 days
after December 31, 1999)
------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0 shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
587,352 shares (includes 83,329 shares which Fletcher Spaght, Inc. has
the right to acquire within 60 days after December 31, 1999)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not Applicable
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ---------------------- ------------------
CUSIP No. 629294 10 9 13G Page 3 of 6 Pages
- ---------------------- ------------------
Item 1(a) Name of Issuer:
NMT Medical, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
27 Wormwood Street
Boston, MA 02210
Item 2(a) Name of Person Filing:
Fletcher Spaght, Inc.
Item 2(b) Address of Principal Business Office or, if none, Residence:
222 Berkeley Street
Boston, MA 02116-3761
Item 2(c) Citizenship:
State of Delaware
Item 2(d) Title of Class of Securities:
Common Stock, $.001 par value per share
Item 2(e) CUSIP Number:
629294 10 9
Item 3 Description of Person Filing:
Not applicable.
Item 4 Ownership:
(a) Amount Beneficially Owned:
587,352 shares (includes 83,329 shares which Fletcher
Spaght, Inc. has the right to acquire within 60 days
after December 31, 1999)
<PAGE>
- ---------------------- ------------------
CUSIP No. 629294 10 9 13G Page 4 of 6 Pages
- ---------------------- ------------------
(b) Percent of Class:
5.4%
(c) Number of shares as to which person has:
(i) sole power to vote or to direct the vote:
587,352 shares (includes 83,329 shares which
Fletcher Spaght, Inc. has the right to
acquire within 60 days after December 31,
1999)
(ii) shared power to vote or to direct the vote:
0 shares
(iii) sole power to dispose or to direct the
disposition of:
587,352 shares (includes 83,329 shares which
Fletcher Spaght, Inc. has the right to
acquire within 60 days after December 31,
1999)
(iv) shared power to dispose or to direct the
disposition of:
0 shares
Item 5 Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another
Person:
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Not applicable.
<PAGE>
- ---------------------- ------------------
CUSIP No. 629294 10 9 13G Page 5 of 6 Pages
- ---------------------- ------------------
Item 8 Identification and Classification of Members of the Group:
Not applicable.
Item 9 Notice of Dissolution of Group:
Not applicable.
Item 10 Certification:
Not applicable.
<PAGE>
- ---------------------- ------------------
CUSIP No. 629294 10 9 13G Page 6 of 6 Pages
- ---------------------- ------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 10, 2000 FLETCHER SPAGHT, INC.
By: /s/ R. John Fletcher
--------------------------
Name: R. John Fletcher
Title: Chief Executive Officer
